Which Antidepressants Are Metabolized by the Liver?
Essentially all antidepressants are primarily metabolized and eliminated by the liver, with renal excretion playing only a minor role in their clearance. 1
General Hepatic Metabolism Profile
The evidence is unequivocal: antidepressants as a class undergo extensive hepatic metabolism as their primary route of elimination. Key pharmacokinetic characteristics include:
- High first-pass metabolism (systemic bioavailability: 10-70%)
- Low renal excretion of parent compounds
- Slow elimination from plasma (half-life 12-36 hours), mainly by hepatic metabolism
- Important effect of hepatic insufficiency on drug elimination 1
Primary Hepatic Enzyme Systems
Antidepressants are metabolized through two main hepatic enzyme systems:
- Cytochrome P450 enzymes (primary system)
- UDP-glucuronosyltransferases (secondary system) 1
Specific CYP Enzymes Involved
CYP2D6 substrates include:
- All tricyclic antidepressants
- SSRIs: paroxetine, fluoxetine
- Third-generation: venlafaxine, mirtazapine 2, 1
CYP2C19 substrates include:
- Tertiary amines: amitriptyline, citalopram (N-demethylation pathway) 1
CYP3A4/5 substrates are also common among antidepressants 1
Clinical Implications
Hepatic Impairment Considerations
Dose adjustment is critical in liver disease because:
- Most antidepressants are predominantly metabolized by the liver
- Many are associated with dose-dependent adverse reactions
- No surrogate parameter exists to predict hepatic metabolism 3, 4
The classification by hepatic extraction ratio helps predict kinetic behavior:
- High extraction drugs: 29.3% of hepatically-metabolized antidepressants
- Intermediate extraction drugs: 25.2%
- Low extraction drugs: 38.4% 4
Genetic Polymorphism Impact
Poor metabolizers (PMs) of CYP2D6 (5-8% of Caucasians) face:
- Higher risk for adverse effects
- Elevated plasma concentrations
- Potential toxicity 1
Ultrarapid metabolizers (UMs) of CYP2D6 (1-7% of Caucasians) experience:
- Higher risk for nonresponse
- Subtherapeutic plasma concentrations 1
Specific SSRI Metabolism
All SSRIs are cleared almost entirely by hepatic metabolism 5, 6:
- Fluoxetine: Extensive hepatic metabolism, produces active metabolite (norfluoxetine)
- Paroxetine: Extensive hepatic metabolism, oral clearance 167 L/h after single dose
- Sertraline: Extensive hepatic metabolism, produces active metabolite (desmethylsertraline)
- Fluvoxamine: Extensive hepatic metabolism
- Citalopram: Nearly 100% bioavailability but still hepatically metabolized, oral clearance 26 L/h 5, 6
Critical Pitfalls
Avoid assuming renal function matters significantly - renal insufficiency has minimal effect on plasma kinetics of antidepressants and their metabolites 1
Do not overlook drug interactions - high risk for inhibition of drug metabolism by comedications that inhibit cytochrome P450 enzymes 1
Consider pharmacogenetic testing for CYP2D6 and CYP2C19 when prescribing antidepressants metabolized by these enzymes, particularly in patients with unexpected adverse effects or treatment failure 2, 1